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Introduction
Abnormal fibrinogen levels and fibrin clot structure have been associated with several pathological conditions including cardiovascular disease, arteriosclerosis, and bleeding disorders. 1, 2 The N-termini of the fibrinogen (A B )2 chains form the central E region, which extends via a coil-coiled region to two terminal D regions. A flexible portion of the A chain-the C regionextends from the ends of the D regions and is tethered to the central E region. 3, 4 To initiate fibrin polymerization, thrombin cleaves fibrinopeptides A and B from the A and B chains of fibrinogen to form fibrin monomers ( )2. 5, 6 These cleavages lead to protofibril formation among the monomers and also releases the C region.
4, 7, 8
At the final stage of blood coagulation, Factor XIIIa (FXIIIa) introduces -glutamyl--lysyl isopeptide bonds between selective glutamines (Q) and lysines (K) within fibrin to form a clot with enhanced elastic properties. 6, [9] [10] [11] [12] [13] Moreover, the overall fibrin network has decreased fiber diameter, increased fiber density, reports of thinner fibers, and increased clot stiffness. 11, [14] [15] [16] FXIIIa first crosslinks fibrin Qγ98 or Qγ99 to fibrin K406 thereby forming -dimers. Crosslinks involving the fibrin chain appears later and involves the generation of -dimers, -hybrids, and higherpolymers.
17-20
Five known reactive glutamines in the C region include Qββ1 (and/or ββγ), Qβγ7, Q328, and Q366. 16, [21] [22] [23] FXIIIa also crosslinks 2-antiplasmin ( 2AP), plasmin activator inhibitor 2 (PAI-2), and fibronectin into the fibrin clot network. [24] [25] [26] [27] FXIII(a) and fibrinogen play additional supporting roles in the presence of red blood cells (RBC). FXIII binding to fibrinogen γ90-396
and subsequent crosslinking of the alpha chain helps mediate RBC retention in venous thrombi.
28, 29
The C region of fibrinogen contributes its own critical roles in the assembly and properties of clot structure. 8, [30] [31] [32] [33] This region has also been directly correlated with adhesion events.
34-36
Fibrinogen C region (ββ1-610) is composed of a flexible C connector (ββ1-391) and a more structured C domain (γ9β-610).
4, 7
During fibrin polymerization, crosslinking in the C region has been shown to promote lateral aggregation and protofibril staggering. 8, 30, 37 Studies with native fibrinogen versus the mutant ( Qγ98N, Qγ99N, K406R) have revealed independent contributions coming from -crosslinks. 16 , 38 Such crosslinks play major roles in promoting clot stiffness, fiber straightening, and hindering fibrinolysis.
Truncations to the C region have been shown to alter the nature of the clot formed.
With
Fibrinogen Otago, the A chain ends at Pβ70 resulting in severe hypofibrinogenemia. Further analysis revealed that loss of (271-610) leads to impaired fibrin polymerization and the production of much thicker fibers. 32, 33, 39 Fibrinogen Seoul II (Q328P mutation) exhibits impaired fibrin polymerization and a reduced extent of -crosslinking due in part to loss of a reactive glutamine within the C region.
40
Several studies have identified specific crosslinking sites in the C region responsible for lateral aggregation but little is known about the individual reactive glutamines and the roles played by the surrounding residues. 17, 18, 20, 22, 23, 41, 42 Antibody studies by Procyk et al., identified a FXIIIa binding site within C (β4β-4β4) and then narrowed the site more specifically to C (γ89-402). (thrombin-activated) and A2B2 involves C (γ71-425) with E396 playing an important role. 44, 45 In close proximity to this FXIII binding region, C (βγγ-425) contains three reactive glutamines (Q237, Q328, and Q366) that each become crosslinked to a selective set of lysines within the fibrin clot network.
17, 23
The aim of the current study was to characterize the glutamines within the fibrinogen C region (233-425) that are known to be crosslinked by FXIIIa under physiological conditions. Matrixassisted laser desorption/ionization time of flight (MALDI-TOF) mass spectrometry and 2D
FXIIIa-catalyzed reactions between the substrate glutamines in C (βγγ-425) and a set of lysine mimics. 46 The results demonstrate that Qβγ7 is the most reactive glutamine of fibrinogen C (βγγ-425) followed by Q366 and Q328. Moreover, no glutamine is dependent on another to react first in the series. New knowledge gained about these three glutamines is considered relative to the conformational features of fibrinogen and to the mutants Fibrinogen Otago and Fibrinogen Seoul II.
Materials and methods

Proteins and chemicals
Human cellular FXIII was a generous gift from the late Dr. Paul Bishop. Stock aliquots of FXIII were prepared in 18 M deionized water and the concentration measured on a Cary 100 Bio UVVisible spectrophotometer using an extinction coefficient of 1.49 (ml mg -1 cm -1 ) and stored at -70 ºC. Thrombin and glycine ethyl ester (GEE) were obtained from Sigma Aldrich (St. Louis, MO). 15 NH4Cl and 15 N-GEE were obtained from Cambridge Isotope Laboratories (Andover, MA).
Site-directed mutagenesis of C (233-425) to generate Q to N substitutions
The PGEX-6P-1 plasmid vector contained cDNA for GST-tagged C fragment (233-425). This C sequence was derived from the full-length fibrinogen A chain cDNA. 44 Individual glutamine substitutions, Q237N, Q328N, and Q366N, were introduced into C (233-425) using the QuikChangeII Site-Directed Mutagenesis Kit (Agilent Technologies, Santa Clara, CA). The resulting substitutions were confirmed with DNA sequencing. DNAs coding for the different C (233-425) species were transformed into BL21 Gold DE3 E. coli cells.
Fibrinogen C (233-425) expression
GST-C (233-425) and its mutants were expressed as described previously by Smith et al. 44 with few modifications. Briefly, GST-C expressing cells were incubated in Terrific Broth (1.β% typtone, 2.4% yeast extract, 0.4% glycerol, 742 mM K2HPO4, 171 mM KH2PO4, and 0.1 mg/ml ampicillin) at γ7°C on a rotary shaker until the optical density at 600 nm reached 0.9. C expression was induced with 1 mM isopropyl -D-1-thiogalactopyranoside (IPTG) followed by incubation at 30°C for 16 h. Cells were harvested by centrifugation at 5000 g at 4°C. Biomass was resuspended in Wash Buffer (20 mM Tris Base pH 8.0, 50 mM NaCl) and centrifuged at 5000 g at 4°C. Resulting pellets were stored at -20°C.
Frozen pellets were resuspended in phosphate buffer saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4, pH 7.4) and incubated with 1 mM dithiothreitol and 1 mg/ml lysozyme, followed by the addition of 2 µg/ml aprotinin, 1 µM pepstatin A, 10 µM leupeptin, 4 mM benzamidine hydrochloride, 0.5 mM phenylmethansulphonylfluoride (PMSF), 0.05% sodium deoxycholate, 0.02% triton X-100, 5 µg/ml Dnase I, and 5 mM MgCl. The Dnase I reaction was quenched with 6 mM EDTA, and the lysate was centrifuged at 22,000 g at 4°C. Supernatant was supplemented with 1% (w/v) streptomycin sulfate and centrifuged at 22,000 g at 4°C. The resulting soluble fraction was passed through a 0.2 µm membrane filter and loaded on a GST-affinity column using an AKTAprime™ system (Amersham Biosciences, Piscataway, NJ). The ability of FXIIIa to crosslink each reactive glutamine in C (233-425) to the lysine mimic GEE was monitored using our previously optimized MALDI-TOF mass spectrometry kinetic assay. 47 Final concentrations of 500 nM FXIII, 17 mM GEE, 4 mM CaCl2, and MALDI assay buffer All samples were subjected to proteolytic digestion with chymotrypsin and GluC (Roche, Indianapolis, IN). For the digests, 6 L of either the control or time point sample were combined with 6 L chymotrypsin buffer (100 mM Tris-HCl, 10 mM CaCl2 pH 7.4) and 1.5 L chymotrypsin
(1 g/L) and incubated for 1 hr at 25C. This digest was quenched with 2 L 5% TFA. GluC digest was performed in a similar manner with 6 L of the sample, 6 L GluC buffer (25 mM NH4HCO3 pH 7.8) and 1.5 L GluC (0.05 g/L) incubated for 2hrs at 25C and quenched with 5% TFA. All digested samples were zip-tipped and analyzed using a MALDI-TOF mass spectrometer (Applied Biosystems Voyager DE-PRO).
47
-Cyano-4-hydroxycinnamic acid (CHCA) matrix was employed for chymotrypsin digests and ferulic acid matrix for GluC. This assay was done in triplicate using C (233-425) from three independent expression trials. The peak-height ratio method was utilized to determine the extent of crosslinking of GEE to each reactive glutamine with time.
The amount of reactant left at each time was calculated as follows: HSQC, the parameters used were nt =64, ni = 64, np = 2048 and sw =7022.5. The spectra were processed using NMRPipe and nmrDraw.
48
Results
Preparation and characterization of recombinant C (233-425)
Recombinant C (233-425) containing an N-terminal GST-tag and a PreScission TM protease cleavage site was expressed in E.coli and purified. SDS-PAGE results and Western Blot analysis using an anti-GST antibody confirmed that there was no GST-C or free GST protein detected in the C samples. The amino acid sequence of C (βγγ-425) can be found in Figure 1A .
MALDI-TOF mass spectral analysis of separate chymotrypsin and GluC digests of C ( Table 1 ).
Monitoring crosslinking of Q237, Q328, and Q366 with GEE
Our MALDI-TOF mass spectrometry kinetic assay was used to monitor FXIIIa-catalyzed crosslinking of each reactive C (233-425) glutamine to the lysine mimic GEE. The crosslinking reaction was quenched at distinct time points and then digested separately with appropriate protease.
A representative set of mass spectral data for a chymotrypsin ( Figure 2A ) and a protease GluC digest ( Figure 2B ) show the reactant peak containing the Q of interest and the subsequent product peak (+ 86 m/z for the new Q-GEE). No reactions products were observed in the absence of FXIIIa.
The amount of reactant left after each time point was calculated using the peak height ratio method. As shown in Figures 2 and 3A , the peptide containing Q237 was rapidly crosslinked by 20 seconds and completely depleted by 5 minutes of reaction with GEE. FXIIIa was able to very effectively crosslink the lysine mimic GEE to the Q237 side chain amine. Q328 and Q366 could also undergo FXIII-catalyzed crosslinking with GEE but at a slower rate than Q237. A plot displaying all three C glutamines indicates that the order of reactivity toward GEE crosslinking was Q237 >> Q366 ≈ Q328. Reactions with Q366 and Q328 could be brought closer to completion by increasing the FXIIIa concentration by 3-fold and the incubation time to 120 minutes ( Figure   3B ). When the original FXIIIa concentration was reduced 15-fold, the Q237 reaction rate became much slower with a 50% loss of reactant occurring by 5 minutes (data not shown). There have been previous reports on the -chain glutamine residues that can be crosslinked by FXIIIa and the lysine partners involved. 23, 42 Using the current assay strategy, the individual reactivities of each glutamine could, for the first time, be directly monitored. Figure 4B and 4C). The high intensity peak for Q237 matches well with the highest reactivity observed with the MALDI-TOF mass spectrometry kinetics assay and followed by Q366
and Q328.
DISCUSSION
Within a blood clot, FXIIIa introduces -glutamyl--lysyl crosslinks between specific reactive glutamines and lysines located in the fibrin and chains. 12, 13, 17, 41 Little is known about the individual contributions of each reactive glutamine and how FXIII selects one glutamine over another. We characterized and ranked three reactive glutamines in fibrinogen C (βγγ-425) for their abilities to be crosslinked by FXIIIa to the lysine mimic GEE. MALDI-TOF mass spectrometry and NMR strategies were employed that would allow us to directly measure individual reactivities.
Several studies have demonstrated that FXIIIa first introduces -crosslinks into the blood clot followed by -crosslinks. 15 Curiously, there is no obvious consensus sequence for the Q-containing substrates of FXIIIa. [50] [51] [52] The reactive glutamines are often found in flexible regions of the substrates. It is important to point out that not all freely available glutamines are good FXIII substrates. Fibronectin contains three glutamines toward its N-terminus but only Q3 is highly reactive, minor crosslinking involves Q7 and Q9. and assess effects of peptide length. [53] [54] [55] By contrast, similar sized peptides based on the fibrinogen A and chains make poor Q-substrates for FXIIIa. 56, 57 These observations suggest that fibrinogen chains require a larger, more protein-like environment to promote substrate specificity.
C (βγγ-425), containing close to 200 amino acids, has been shown to be a highly promising system for probing the FXIIIa substrate specificity toward the A chain.
44, 45
C (βγγ-425) has three reactive glutamines and a putative FXIIIa binding site. GEE serves successfully as a lysine mimic and targets physiological, reactive glutamines. 18, 55, 57 Unlike spectrophotometric assays that indirectly monitor crosslinking activity or SDS PAGE gels that provide more general conclusions about crosslinking, our mass spectrometry kinetic assay directly follows each reactive glutamine.
By focusing on C (βγγ-425), the challenges of working with multiple, competing glutamines and lysines both on fibrinogen A and chains were also avoided.
Using the MALDI-TOF mass spectrometry assay, we were able, for the first time, to rank the individual glutamine players in fibrinogen C (βγγ-425). Results revealed that Q237 was the most reactive followed by Q366 and Q328. Our complementary NMR techniques validated these findings. Interestingly, the C region is proposed to be mostly disordered and no X-ray crystallographic information is available. Despite this disordered nature, all three glutamines in C A based peptides, we propose that the larger C (βγγ-425) exhibits some localized conformational environment that allows or promotes interactions with FXIIIa.
The C reactivity ranking Qβγ7 >> Qγ66 ≈ Qγβ8 provides new information to help interpret crosslinking pairs reported recently for full length fibrinogen. 23 For that study, the FXIIIa catalyzed crosslinking reactions were followed by trypsin digests and mass spectral analysis. Wang demonstrated that Qβγ7 could be crosslinked to more lysine pairs ( K418, K508, K5γ9 K556
and K601) than all other reactive glutamines that were probed.
23
The high reactivity we documented for Q237 suggests that this amino acid is well positioned to crosslink a variety of reactive lysines. Unlike Qβγ7, Wang reported that C Qγ66 only crosslinks to K5γ9. It should be noted that Q328 was not identified in Wang's study. Previous investigations, however, have shown that Q328 is an important reactive glutamine. 22, 40 In our assay, we were able to characterize Q328
following a chymotrypsin digest. Our ability to monitor all three reactive glutamines simultaneously in C (βγγ-425) is enhanced by digesting each sample time point separately with chymotrypsin and Glu C (Figure 1 ).
Using an NMR assay, we were able to confirm that FXIIIa crosslinks both 15 and Q366 are shown to be crosslinked to GEE by FXIIIa (Figure 4) . Thus, FXIIIa does not need to crosslink the fast acting C Qβγ7 before moving on to the other reactive glutamines. Further mutant combinations reveal that if any of the three Qs is replaced with a nonreactive N, the other two Qs can still participate in the crosslinking reactions (Figure 4) . The data collected thus far suggest there is no obvious sequentiality in FXIIIa crosslinking.
Our current results can also be considered relative to disease-associated fibrinogen truncations and mutants. In Fibrinogen Otago, a major portion of the C region (β71-610) is absent and in Fibrinogen Keokuk, a single point mutation changes Q328 to a stop codon generating a larger truncation. 40, 58 In both cases, Q221, Q223, and Q237 are still available for crosslinking by FXIIIa but Q328, Q366, and multiple reactive lysines are missing. Our MS assay suggests that Q237 is highly reactive and the Wang studies revealed that this glutamine interacts with several lysines.
FXIIIa may catalyze a heterodimeric reaction between fibrin C Qβγ7 and fibrin K406. In normal fibrinogen, the -heterodimer has been reported to make up β% of the fibrin crosslink contributions, but the reactive Q and K partners have not been identified. 59 C Qβγ7 (and/or Qββ1, Qββγ) might therefore help support the dominant fibrin -crosslinks observed in SDS-PAGE gels of Fibrinogen Otago treated with FXIIIa and calcium.
In Fibrinogen Seoul II, a single point mutation results in C Qγβ8 being replaced with proline (Qγβ8P). With this mutation, fibrin -crosslinking occurs but -is impaired. 40 Considering our data, Q237 and Q366 would still be available in the Seoul II patients along with potential K residues in the more C-terminal portion of C. Multiple crosslinks involving highly reactive Q237 may, however, not be sufficient to overcome the introduction of Q328P.
Recombinant variants that model Fibrinogen Seoul II revealed that Q328P/Q366P exhibited greater impairment of fibrin polymerization than the single mutants Q328P or Q366P. 60 The current work with C (βγγ-425) suggests Q328 and Q366 exhibit similar reactivities. With each single P substitution, the pyrrole group may induce a conformational change that hinders fibrin architecture and subsequent crosslinking. A greater disruption occurs with the double mutant. Fibrincrosslinking, however, was still observed and likely involved Q237, Q221, and/or Q223. Unlike working with Q328P and Q366P, our Q to N substitutions within C (βγγ-425) provide a more conservative strategy for understanding the contributions of the different reactive Q residues.
Moreover, any glutamines still present within C mutants can be individually monitored and kinetically ranked. Q237 always remained the most reactive glutamine but no obvious sequentiality in FXIIIa crosslinking was observed. Park and coworkers propose that conformational problems resulting from P328 help explain the consequences of Seoul II. Another possibility to consider is that crosslinks containing Q328 (and/or Q366) play structural roles within the fibrin clot that differ from those of Q237, Q221, and Q233. These issues can be further probed in the future using full chain fibrinogens.
In summary, we have characterized and ranked three known reactive glutamines Q237, Q328, and Qγ66 in fibrinogen C (βγγ-425) using a MALDI-TOF mass spectrometry kinetics assay and a complementary βD HSQC NMR approach. C Qβγ7 was shown to be the most reactive glutamine *MS/MS analysis on the peptide containing Q237 revealed that amino acids GPLGS are located just N-terminal to the C 233-425. These amino acids remain following PreScission protease cleavage of the GST-C (233-425). The sequences containing Q328 and Q366 were readily identified using a theoretical protease digest (Protein Prospector UCSF).
